亚洲 · 区域市场 · CNBC-TV18
Alembic Pharmaceuticals Q2 Results: Shares jump 20% after profit rises 81%; US business grows 77%
In the international business, the US formulations segment recorded a 77% increase in revenue to ₹1,003 crore. The company launched three products in the US market during the…
在 CNBC-TV18 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.cnbctv18.com)
